title: Lack of association of polymorphisms of the lymphotoxin alpha gene with myocardial infarction in Japanese.
abstract: Vascular inflammation plays an important role in the development of myocardial infarction (MI). Lymphotoxin alpha (LTA) is a cytokine with multiple functions in regulation of the immune system and inflammatory reactions. The aim of this study was to examine whether polymorphisms of the LTA gene are associated with the risk of MI in Japanese men and women. A case-control association study was performed for the 252A-->G and 804C-->A polymorphisms of the LTA gene and the prevalence of MI. The study population comprised 3,689 unrelated Japanese individuals (2,486 men, 1,203 women), including 1891 patients with MI (1,493 men, 398 women) and 1798 control subjects (993 men, 805 women). Among the control subjects 257 individuals (108 men, 149 women) who had none of the conventional risk factors for coronary artery disease (CAD) were defined as low-risk controls. Genotypes for the two polymorphisms were determined with a fluorescence-based allele-specific DNA primer assay system. Among all study subjects the 252A-->G and 804C-->A polymorphisms exhibited linkage disequilibrium. No association of either polymorphism with MI was detected in men or in women in comparisons with total control or low-risk control subjects. However, each of the two polymorphisms was associated with the prevalence of type 2 diabetes mellitus both in men with MI and in those without MI in a recessive genetic model. No association was detected between the polymorphisms and other conventional risk factors for CAD. The LTA gene thus does not appear to be a susceptibility locus for MI in Japanese men or women, although it might affect susceptibility to type 2 diabetes in Japanese men.
authors.affiliation: Department of Clinical Pathophysiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, 466-8550 Nagoya, Japan.
authors.forename: Akira
authors.initials: A
authors.lastname: Yamada
authors.forename: Sahoko
authors.initials: S
authors.lastname: Ichihara
authors.forename: Yosuke
authors.initials: Y
authors.lastname: Murase
authors.forename: Tomoko
authors.initials: T
authors.lastname: Kato
authors.forename: Hideo
authors.initials: H
authors.lastname: Izawa
authors.forename: Kohzo
authors.initials: K
authors.lastname: Nagata
authors.forename: Toyoaki
authors.initials: T
authors.lastname: Murohara
authors.forename: Yoshiji
authors.initials: Y
authors.lastname: Yamada
authors.forename: Mitsuhiro
authors.initials: M
authors.lastname: Yokota
mesh_terms: D000368:Aged; D003324:Coronary Artery Disease / Q000235:genetics; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics; D005260:Female; D006801:Humans; D007107:Immune System; D007249:Inflammation / Q000235:genetics / Q000276:immunology; D007564:Japan; D015810:Linkage Disequilibrium / Q000235:genetics*; D008233:Lymphotoxin-alpha / Q000235:genetics* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D011110:Polymorphism, Genetic; D014657:Vasculitis / Q000150:complications / Q000235:genetics / Q000276:immunology
chemical_list: D008233:Lymphotoxin-alpha